News

Lumen (NYSE: LUMN) stock got hit hard in Tuesday's trading. Its share price was down 10% just before market close on news that the company could wind up selling one of its units to AT&T. The stock

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities broadly remain down for the year. Still, some companies are performing

Multiple paths to immense wealth exist. A few lucky people win the lottery. Some start successful businesses. Others invest in stocks that deliver explosive gains.

Summit Therapeutics (NASDAQ: SMMT)

AT&T (NYSE: T) stock offers passive income investors a robust dividend yield and the chance for an increasing stock price.

*Stock prices used were the afternoon prices of March 19, 2025. The video

Last year, Summit Therapeutics (NASDAQ: SMMT) was one of the stars of the biotech industry. The company's shares soared following a significant clinical win. Summit's market capitalization of $15.3

Three catalysts drove AT&T's (NYSE: T) stock price nearly 50% higher over the past two years.

Image source: Getty Images.

From 2024 to 2027, analysts expect AT&T's EPS to grow at a compound annual

The new year started off with considerable fanfare for the cryptocurrency market. Under President Donald Trump's crypto plan, America was going to become "the crypto capital of the world." That

A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock price pop. That upward lift was largely holding as of Friday before

If you've got $5,000 that you can afford to invest in the stock market, you may want to consider putting that money into dividend stocks. Fears of an imminent recession are mounting,  and dividend

Summit Therapeutics (NASDAQ: SMMT) has been one of the hottest stocks to own over the past 12 months, with its valuation soaring 300% during that stretch. But things have slowed of late and since

Image source: The Motley Fool.

Amarin Plc (NASDAQ: AMRN)Q4 2024 Earnings CallMar 12, 2025, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

AT&T's (NYSE: T) stock turnaround has been one of the more surprising happenings in the stock market over the past 12 months. Its stock is up by around 52% in that span and has nearly touched its

Shares of veteran telecom company AT&T (NYSE: T) saw a resurgence in recent months. The stock hit a 52-week high of $27.97 on March 4, the highest it's been in years, and is up more than 50% over

Finding stocks that will outperform the market is no easy task. Indeed, according to First Trust advisors, only 28% of stocks outperformed the S&P 500 in 2024.

That said, it's not impossible to

In this video, Motley Fool contributor Jason Hall explains why AT&T (NYSE: T), after a great 19 month run, isn't likely to outperform the market going forward.

*Stock prices used were from the

Viatris (NASDAQ:VTRS), a global healthcare company known for its broad portfolio of pharmaceutical products, released its fourth-quarter 2024 results on Feb. 27. Despite achieving substantial debt

The U.S. stock market, characterized by the S&P 500, has been on a tear since the artificial intelligence (AI) revolution began in early 2023. The index has risen approximately 24% over the past

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy increase in value. But which stocks are likely to deliver growth over the

While many investors focus on a company's stock price, dividends can often be unsung heroes when it comes to making money. Dividend stocks may not be as sexy as growth stocks or get much of the same

If you're content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not, you'll need to find stocks that hold the potential to pack more punch.

Three

Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last year's strong market rally. Both finished 2024 slightly in the red. They're

Shares of BigBear.ai Holdings (NYSE: BBAI) are flying higher on Wednesday. The company's stock gained 11.6% as of 12:35 p.m. ET, but was up as much as 15.5% earlier in the day. The gain comes as the

Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (NASDAQ: SMMT). The drugmaker's shares are up by nearly 540%, thanks to excellent clinical

While much of the investing world has been focused on artificial intelligence, one under-the-radar stock winner over the past year has been AT&T (NYSE: T). Shares of the telecom giant are up by more

A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday. Investors were clearly impressed by the pharmaceutical company's numbers, as